title: Quality improvement case study: warfarin sodium interactions.
abstract: Dangerous Interactions Involving Antibiotic Use In Warfarin-Treated Nursing Facility Residents FACTS OF THE INCIDENT: All names, places and dates and some details have been changed to protect the confidentiality of this actual event.
authors.affiliation: University of South Carolina School of Medicine, Columbia, SC, USA. andrew.weinberg@med.va.gov
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Weinberg
authors.forename: Julie S
authors.initials: JS
authors.lastname: Altman
authors.forename: Jean K
authors.initials: JK
authors.lastname: Pals
mesh_terms: D000058:Accidental Falls; D000368:Aged; D000892:Anti-Infective Agents, Urinary / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects*; D003221:Confusion / Q000139:chemically induced; D016903:Drug Monitoring; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005853:Geriatrics / Q000458:organization & administration*; D006801:Humans; D019934:International Normalized Ratio; D020300:Intracranial Hemorrhages / Q000139:chemically induced; D008318:Malpractice / Q000331:legislation & jurisprudence; D009735:Nursing Homes / Q000458:organization & administration; D016134:Organizational Policy; D011516:Prothrombin / Q000032:analysis; D012308:Risk Management / Q000458:organization & administration; D017749:Total Quality Management / Q000458:organization & administration*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects; D014859:Warfarin / Q000009:adverse effects*
chemical_list: D000892:Anti-Infective Agents, Urinary; D000925:Anticoagulants; D014859:Warfarin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D011516:Prothrombin